安杨，副教授，博士，硕士研究生导师。中国微循环学会转化医学专业委员会青年委员，河南省抗癌协会肿瘤临床精准诊断与治疗专业委员会委员，河南省生物化学与分子生物学学会理事。2013年入职河南大学基础医学院，在生物化学与分子生物学教研室从事教学工作，承担本科生《生物化学与分子生物学》、《神经生物学》、《分子生物学实验技术》和研究生《基因工程》等教学工作，并开设有特色课程—本科生拓展性实验课《实时荧光定量PCR》和《Western blotting》，旨在提升学生的动手操作能力和科研思维。作为指导教师指导10项大学生创新创业训练计划项目（其中5项国家级和3项校级项目均已顺利结题）和大学生科学研究类竞赛（获得二等奖、三等奖等优异成绩）。指导多名本科生进行科研训练和毕业设计，获得奖学金、保研名额、顺利毕业。荣获第三届中部三省(河南、湖北、湖南)生物化学与分子生物学教学微课赛二等奖。科研方面，先后在学术杂志上发表多篇SCI论文，主持和参与多项科研项目。在河南大学工作期间发表SCI论文31篇，其中第一及通讯作者论文10篇，一区1篇，二区6篇，三区3篇，四区1篇。主持1项河南省重点研发与推广专项（科技攻关）项目（已结题）。主持1项河南省高等学校重点科研项目（已结题），主持1项河南大学科学研究基金项目（已结题）。获得河南省教育厅科技成果奖二等奖。指导多名研究生开展学术课题、掌握实验技术、撰写毕业论文并顺利取得硕士学位、获得奖学金等。

发表SCI论文：

(1) Lu Xiaoyan#, Zhang Yuanyuan#, Yang Pei, Yi Minjun, Wang Luyao, Chen Jing, Wang Han, Li Mengke, Jiang Yufei, Guo Bingbing, Lu Wenyuan, Li Shijia, Chen Jiahao, Lian Yingying, Li Xinyu, Zhao Binbin, Wang Xiaoqing*,An Yang*. Comprehensive prognostic signatures in thyroid cancer-review for molecular signatures construction strategies.Gene & Protein in Disease. 2023, 2(3):1138.

(2) Li Xinyu#, Wu Jialin#, Yue Man, Hou Mengwen, Han Jiayang, Zhao Binbin, Sun Tiantian, Han Xu, Liu Guangchao, Zhang Kaifeng, Wu Tinggai, Ye Ting, Tu Mengjie,An Yang*. High expression of apoptosis-related LMNB2 predicts an unfavorable outcome: A potential prognostic biomarker for liposarcoma.Gene & Protein in Disease. 2024.In press.https://doi.org/10.36922/gpd.2607.

(3) Guo Ge#, Wang Wanli#, Tu Mengjie, Zhao Binbin, Han Jiayang, Li Jiali, Pan Yanbing, Zhou Jie, Ma Wen, Liu Yi, Sun Tiantian, Han Xu,An Yang*. Deciphering adipose development: Function, differentiation and regulation.Developmental Dynamics. 2024, 1–42. doi: 10.1002/dvdy.708. Online ahead of print.

(4) Sun Leilei, Ji Shaoping, Xie Xuan, Si Lei, Liu Shaohao, Lin Yao, Wang Yahui, SongZhenhua, Fang Na,An Yang*, Yang Jian*. Deciphering the interaction between Twist1 and PPARγ during adipocyte differentiation.Cell Death & Disease. 2023: 14(11):764.

(5)An Yang#*, Lu Wenyuan#, Li Shijia, Lu Xiaoyan, Zhang Yuanyuan, Han Dongcheng, Su Dingyuan, Jia Jiaxin, Yuan Jiaxin, Zhao Binbin, Tu Mengjie, Li Xinyu, Wang Xiaoqing, Fang Na*, Ji Shaoping*. Systematic review and integrated analysis of prognostic gene signatures for prostate cancer patients.Discover Oncology. 2023: 14: 234.

(6) Chen Jiahao#; Lian Yingying#; Zhao Binbin; Han Jiayang; Li Xinyu; Wu Jialin; Hou Mengwen; Yue Man; Zhang Kaifeng; Liu Guangchao; Tu Mengjie; Ruan Weimin; Ji Shaoping;An Yang*; Deciphering the Prognostic and Therapeutic Significance of Cell Cycle Regulator CENPF: A Potential Biomarker of Prognosis and Immune Microenvironment for Patients with Liposarcoma, International Journal of Molecular Sciences.2023, 24(8): 7010.

(7) Wang Xiangze, Zhao Minghui, Zhang Chensheng, Chen Haobo, Liu Xingyu,An Yang, Zhang Lu*, Guo Xiangqian*. Establishment and Clinical Application of the Nomogram Related to Risk or Prognosis of Hepatocellular Carcinoma: A Review.Journal of Hepatocellular Carcinoma. 2023, 10: 1389-1398.

(8) Liu Yanjie#; Zhang Dongya#;An Yang; Sun Yajing; Li Jia; Zheng Meng; Zou Yan*, Shi Bingyang*; Non-invasive PTEN mRNA brain delivery effectively mitigates growth of orthotopic glioblastoma,Nano Today, 2023, 49: 101790.

(9) Ruan Weimin#; Jiao Mingzhu#; Xu Sen#; Ismail Muhammad; Xie Xuan;An Yang; Guo Haixing; Qian Rongjun*; Shi Bingyang*; Zheng Meng*; Brain-targeted CRISPR/Cas9 nanomedicine for effective glioblastoma therapy,Journal of Controlled Release, 2022, 351: 739–751.

(10)An Yang#; Wang Qiang#; Zhang Guosen; Sun Fengjie; Zhang Lu; Li Haojie; Li Yingkun; Peng Yanyu; Zhu Wan; Ji Shaoping; Guo Xiangqian*; OSlihc: An Online Prognostic Biomarker Analysis Tool for Hepatocellular Carcinoma,Frontiers in Pharmacology, 2020, 11: 875.

(11)An Yang#; Wang Qiang#; Zhang Lu; Sun Fengjie; Zhang Guosen; Huan Dong; Li Yingkun; Peng Yanyu; Li Haojie; Zhu Wan; Ji Shaoping; Wang Yunlong*; Guo Xiangqian*; OSlgg: An Online Prognostic Biomarker Analysis Tool for Low-Grade Glioma,Frontiers in Oncology, 2020, 10: 1097.

(12)An Yang#; Wang Qiang#; Sun Fengjie; Zhang Guosen; Wang Fengling; Zhang Lu; Li Yanan; Ren Weinan; Zhu Wan; Li Yongqiang; Ji Shaoping; Guo Xiangqian*; OSucs: An Online Prognostic Biomarker Analysis Tool for Uterine Carcinosarcoma,Genes, 2020, 11(9): 1040.

(13) Wang Qiang#;An Yang#; Wang Fengling; Zhang Guosen; Zhang Lu; Huan Dong; Xin Junfang; Li Yongqiang; Ji Shaoping; Guo Xiangqian*; OSchol: an online consensus survival web server for cholangiocarcinoma prognosis analysis,HPB, 2020,HPB (Oxford), 2021, 23(4): 545-550.

(14) Zhang Guosen,An Yang, Zhang Lu, Xie Longxiang, Guo Xiangqian*; Risk factors for in-hospital mortality in patients with cancer and COVID-19,Lancet Oncology, 2020, 21(9): e407.

(15) Ruan Weimin; Zheng Meng*;An Yang; Liu Yuanyuan; Lovejoy David B; Hao Mingcong; Zou Yan; Lee Albert; Yang Shu; Lu Yiqing; Morsch Marco; Chung Roger; Shi Bingyang*; DNAnanoclew templated spherical nucleic acid for siRNA delivery,Chemical Communications, 2018, 54(29): 3609-3612.

(16) Xiao Man;An Yang; Wang Fengling; Yao Chao; Zhang Chu; Xin Junfang; Duan Yongjian; Zhao Xiaofang; Fang Na*; Ji Shaoping*; A chimeric protein PTEN-L-p53 enters U251 cells to repress proliferation and invasion,Experimental Cell Research, 2018, 369(2): 234-242.

(17)An Yang#; Wang Shuzhen#; Li Songlin; Zhang Lulu; Wang Dayong; Wang Haojie; Zhu Shibai; Zhu Wan; Li Yongqiang; Chen Wenwu; Ji Shaoping*; Guo Xiangqian*; Distinct molecular subtypes of uterine leiomyosarcoma respond differently to chemotherapy treatment,BMC Cancer, 2017, 17: 639-646.

(18)An Yang; Furber Kendra L; Ji Shaoping*; Pseudogenes regulate parental gene expression via ceRNA network,Journal of Cellular and Molecular Medicine, 2017, 21(1): 185-192.